Pylarify And Theranostics Expansion Will Capture Global Aging Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
20 Jul 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$159.00
66.1% undervalued intrinsic discount08 Aug
US$53.90
1Y
-44.7%7D
-25.8%